Amicus Therapeutics announced two new additions to the senior leadership team. Jill Weimer, Ph.D., a developmental neuroscientist and recognized thought leader in the field of neurologic rare disease gene therapy science, has joined as Senior Vice President of Discovery Research and Gene Therapy Science. Dr. Weimer will report to Hung Do, Ph.D., Chief Science Officer and Jeff Castelli, PhD, Chief Portfolio Officer and Head of Gene Therapy as part of Gene Therapy Center of Excellence Leadership T...